[CYCC] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
29-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -6.40%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 420 0 0 0 0 150 0 -
PBT -25,551 -25,915 -22,734 -9,681 -9,125 -8,625 -8,463 20.21%
Tax -2,996 -4,717 -3,847 -1,236 -1,297 -1,337 -993 20.19%
NP -22,555 -21,198 -18,887 -8,445 -7,828 -7,288 -7,470 20.21%
Tax Rate - - - - - - - -
Total Cost 22,975 21,198 18,887 8,445 7,828 7,438 7,470 20.58%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -5,370.24 0.00 0.00 0.00 0.00 -4,858.67 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -26.75 -32.23 -31.74 -34.86 -143.88 -12.05 -19.58 5.33%
EPS Diluted -26.75 -32.23 -31.74 -34.86 -143.88 -12.05 -19.58 5.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.